[Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].

Abstract

The bisphosphonate, alendronate sodium (e.g. Fosamax), a bone resorption inhibitor used to treat osteoporosis, has occasionally been reported to cause severe oesophagitis. The characteristic endoscopy findings include oesophageal ulceration with discoloured exudate, a narrowed lumen and denuded, haemorrhagic mucosa. The oesophagitis heals on discontinuation… (More)

Topics

Cite this paper

@article{Tth1998AlendronateinducedSE, title={[Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].}, author={Ervin T{\'o}th and F T Fork and K Lindel{\"{o}w and Eva Lindstr{\"{o}m and Hans P Verbaan and B{\'e}la Veress}, journal={Lakartidningen}, year={1998}, volume={95 35}, pages={3676-80} }